Adar1 Capital Management, LLC Ptc Therapeutics, Inc. Transaction History
Adar1 Capital Management, LLC
- $500 Billion
- Q4 2024
A detailed history of Adar1 Capital Management, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 48,023 shares of PTCT stock, worth $2.53 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
48,023
Previous 20,000
140.11%
Holding current value
$2.53 Million
Previous $742 Million
192.15%
% of portfolio
0.43%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding PTCT
# of Institutions
258Shares Held
77.4MCall Options Held
179KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$483 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$409 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$389 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$335 Million4.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.79MShares$252 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.76B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...